- US Capitol Capsule: FDA barks about state restrictions, but where's the bite?
- Industry scrambles to defuse row over "satanic" campaign against South African IP plans
- US Capitol Capsule: Analysts' drug price advice: Define yourself before opponents do
- FDA raises cognitive concerns with PCSK9s; Amgen, Sanofi, Regeneron hit
COMMENT Other Informa Comment
- INTERVIEW: Novo CEO downplays Afrezza, pins hopes on oral pipeline
- INTERVIEW: Dr Reddy's CEO on the 'windshield and rear view mirror'